APA (7th ed.) Citation

Lexis, C. P. H., van der Horst, I. C. C., Lipsic, E., van der Harst, P., van der Horst-Schrivers, A. N. A., Wolffenbuttel, B. H. R., . . . de Smet, B. J. G. L. (2012). Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. Cardiovascular drugs and therapy, 26(5), 417-426. https://doi.org/10.1007/s10557-012-6413-1

Chicago Style (17th ed.) Citation

Lexis, Chris P. H., et al. "Metformin in Non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial." Cardiovascular Drugs and Therapy 26, no. 5 (2012): 417-426. https://doi.org/10.1007/s10557-012-6413-1.

MLA (9th ed.) Citation

Lexis, Chris P. H., et al. "Metformin in Non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial." Cardiovascular Drugs and Therapy, vol. 26, no. 5, 2012, pp. 417-426, https://doi.org/10.1007/s10557-012-6413-1.